Share on StockTwits

Novadaq Technologies (NASDAQ:NVDQ)‘s stock had its “buy” rating reaffirmed by equities research analysts at Stifel Nicolaus in a research note issued to investors on Wednesday. They currently have a $19.00 price target on the stock, down from their previous price target of $20.00. Stifel Nicolaus’ target price suggests a potential upside of 31.40% from the company’s current price.

Several other analysts have also recently commented on the stock. Analysts at RBC Capital cut their price target on shares of Novadaq Technologies from $18.00 to $17.00 in a research note on Wednesday. Separately, analysts at Canaccord Genuity cut their price target on shares of Novadaq Technologies from $21.00 to $18.00 in a research note on Wednesday. Finally, analysts at Northland Securities reiterated an “underperform” rating on shares of Novadaq Technologies in a research note on Tuesday. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $16.09.

Novadaq Technologies (NASDAQ:NVDQ) traded down 1.97% during mid-day trading on Wednesday, hitting $14.46. The stock had a trading volume of 703,449 shares. Novadaq Technologies has a 52 week low of $11.91 and a 52 week high of $24.09. The stock has a 50-day moving average of $16.29 and a 200-day moving average of $17.90. The company’s market cap is $798.0 million.

Novadaq Technologies (NASDAQ:NVDQ) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.11 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.07) by $0.18. The company had revenue of $11.20 million for the quarter, compared to the consensus estimate of $11.33 million. During the same quarter last year, the company posted ($0.05) earnings per share. Novadaq Technologies’s revenue was up 38.3% compared to the same quarter last year. On average, analysts predict that Novadaq Technologies will post $-0.25 earnings per share for the current fiscal year.

Novadaq Technologies Inc develops and commercializes medical imaging and therapeutic devices for use in the operating room.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.